Jorge Ramon Hernandez, a working-class guy from Hialeah, Florida, once had a bright future.
He graduated with a bachelor's degree from the University of Miami and joined the Army after the 2001 terrorist attacks on the United States. He served in Iraq and Afghanistan, working as an Arabic translator as part of an intelligence unit.
But after suffering a back injury in the military, he returned home to Miami and never quite put his life back on track.
The Pineapple Fund, an anonymous benefactor’s initiative to give away $86 million in digital currency, plans to donate $4 million for the study of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder.
The U.S. Food and Drug Administration has designated MDMA as a “breakthrough therapy” for the treatment of post-traumatic stress disorder, a significant milestone in the decades-long effort to turn the notorious illegal party drug — better known as ecstasy or “Molly” — into a prescription medication, Washington Post reports.
Back in the 1990s, before he began studying the medicinal effects of MDMA on patients suffering from severe post-traumatic stress disorder, psychiatrist Dr. Michael Mithoefer would occasionally encounter patients who had experimented with the drug. They had, of course, taken MDMA for the same reason everyone takes MDMA — to experience the face-melting, dance-inducing effects of an illegal substance that is engineered to make you feel really, really good. For Mithoefer’s patients, however, the experience was a little more complicated.